Brief: Addex Therapeutics And Indivior Extend Research Collaboration On Gabab Positive Allosteric Modulators
29/07/2021 06:06
July 29 (Reuters) - ADDEX THERAPEUTICS Ltd ADXN.S :
* ADDEX AND INDIVIOR EXTEND RESEARCH COLLABORATION ON GABAB
POSITIVE ALLOSTERIC MODULATORS - INDIVIOR COMMITS $4 MILLION OF
NEW FUNDING
Source text for Eikon: ID:nGNE5S98F3
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand